Jaceosidin
CAS : 18085-97-7
Ref. TM-T3824
1mg | 56,00 € | ||
5mg | 120,00 € | ||
10mg | 183,00 € | ||
25mg | 369,00 € | ||
50mg | 551,00 € | ||
100mg | 792,00 € | ||
1ml*10 (DMSO) | 87,00 € |
Informations sur le produit
- 3′,6-Dimethoxy-4′,5,7-trihydroxyflavone
- 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-6-methoxy-
- 4′,5,7-Trihydroxy-3′,6-dimethoxyflavone
- 4′-Demethyleupatilin
- 5,7,4′-Trihydroxy-6,3′-dimethoxyflavone
- 5,7-Dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-6-methoxy-4H-1-benzopyran-4-one
- 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-6-methoxy-4H-chromen-4-one
- 6-Hydroxyluteolin 6,3′-dimethyl ether
- 6-Methoxyluteolin 3′-methyl ether
- Flavone, 4′,5,7-trihydroxy-3′,6-dimethoxy-
- Voir d'autres synonymes
- Jaseocidin
Jaceosidin has anti-oxidative activity. Jaceosidin has anti-inflammatory activity, also a microglial inhibitor with anti-neuroinflammation activity. aceosidin has anticancer activity, modulates the ERK/ATM/Chk1/2 pathway, leading to inactivation of the Cdc2-cyclin B1 complex, followed by G2/M cell cycle arrest in endometrial cancer cells. Jaceosidin has immunosuppressive effect through inhibiting T cell proliferation and activation, which is closely associated with its potent down-regulation of the IFN-γ/STAT1/T-bet signaling pathway. The pharmacokinetics of Jaceosidin may be dramatically affected by polymorphic CYP1A2, UGT1A1, and UGT1A7 responsible for the metabolism of Jaceosidin or by the coadministration of relevant CYP1A2 or UGT inhibitors or inducers.
Propriétés chimiques
Question d’ordre technique sur : TM-T3824 Jaceosidin
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages